Last edition
News about "Investigational New Drug "
GC Biopharma Wins IND Approval in Korea for Phase I COVID-19 mRNA Vaccine Trial
GC Biopharma has received IND approval in Korea to initiate a Phase I clinical trial of its COVID-19 mRNA vaccine, marking a key step in advancing its mRNA platform, with plans to submit a Phase II IND in the second half of 2026.
Investigational New Drug | 24/12/2025 | By News Bureau
CASI Pharmaceuticals Plans to Submit IND Application For CID-103
CASI Pharmaceuticals, Inc. has planned to submit an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for CID-103 for the treatment of antibody-mediated rejection (AMR) in kidney transplant recipients by the end of 2024.
Investigational New Drug | 28/06/2024 | By Aishwarya | 554
Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201
Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety
Investigational New Drug | 26/03/2024 | By Manvi | 795
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy